These results provide primary evidence for dysregulation of the splicing machinery in lung carcinoids and suggest a plausible functional role and therapeutic targetability of NOVA1, PRPF8 and SRSF10. The gene discussed is NOVA1; the disease is lung carcinoid tumor.